BAIT

SSN8

CNC1, GIG3, NUT9, RYE2, SRB11, UME3, CycC, L000002796, YNL025C
Cyclin-like component of the RNA polymerase II holoenzyme; involved in phosphorylation of the RNA polymerase II C-terminal domain; forms a kinase-cyclin pair in the RNAPII holoenzyme with Ssn3p; required for both entry into and execution of the meiotic program; involved in glucose repression and telomere maintenance; cyclin homolog 35% identical to human cyclin C
Saccharomyces cerevisiae (S288c)
PREY

GAL1

galactokinase, L000000658, YBR020W
Galactokinase; phosphorylates alpha-D-galactose to alpha-D-galactose-1-phosphate in the first step of galactose catabolism; expression regulated by Gal4p; GAL1 has a paralog, GAL3, that arose from the whole genome duplication
GO Process (3)
GO Function (1)
GO Component (1)
Saccharomyces cerevisiae (S288c)

Dosage Lethality

A genetic interaction is inferred when over expression or increased dosage of one gene causes lethality in a strain that is mutated or deleted for another gene.

Publication

Interaction of a transcriptional repressor with the RNA polymerase II holoenzyme plays a crucial role in repression.

Zaman Z, Ansari AZ, Koh SS, Young R, Ptashne M

The yeast transcriptional repressor Tup1, tethered to DNA, represses to strikingly different degrees transcription elicited by members of two classes of activators. Repression in both cases is virtually eliminated by mutation of either member of the cyclin-kinase pair Srb10/11. In contrast, telomeric chromatin affects both classes of activators equally, and in neither case is that repression affected by mutation of ... [more]

Proc. Natl. Acad. Sci. U.S.A. Feb. 27, 2001; 98(5);2550-4 [Pubmed: 11226276]

Throughput

  • Low Throughput

Ontology Terms

  • phenotype: inviable (APO:0000112)

Curated By

  • BioGRID